Wen Xia, Hai Hu, Xin Wang, Yuping Sun, Zuoxing Niu, Yanqiao Zhang, Huiting Xu, Lixin Wan, Yan Hu, Yuhua Liu, Kangsheng Gu, Zhiguo Luo, Jiajia Huang, Qiufan Zheng, Chuanqi Chao, Shu qiang Song, Shengfeng Li, Shusen Wang, Ning Li. "A phase Ib/IIa study of BAT8010+BAT1006, an anti-HER2 monoclonal antibody-exatecan conjugate combined with an ADCC-enhanced HER2 mAb in patients with advanced solid tumors: Results from the 1L HER2-positive breast cancer cohort.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1046